Very pleased to announce that Dr. Andrés Pizzorno – Signia Therapeutics’ cofounder and Project Manager – has been invited by the Scientific Committee of the Options for the Control of Influenza X Conference, to be held in Singapore from August 28 to September 1 2019, to give a presentation on “Potential host-targeted therapies for influenza”. … Continue reading Signia Therapeutics to be present at the Options for the Control of Influenza X Conference